MODIFIED IMMUNOGENIC PEPTIDE AGAINST STREPTOCOCCUS A
- 總結
- An immunogenic peptide for prevention and treatment of group A streptococcus streptococcus-associated diseases and conditions
- 技術優勢
- Vaccine to prevent group A streptococci infection
- 技術應用
- Vaccine - disease prevention
- 詳細技術說明
- The present inventors have discovered that the immunogenicity of a p145 peptide can be substantially increased by targeted modification of the amino acid sequence of p145. A single immunization with the modified p145 peptide, rather than multiple immunizations, can protect against group A streptococcus infection even by hypervirulent strains such as the CovR/S mutant strain.
- 合作類型
- Licensing
- 申請日期
- 23/08/2017 00:00:00
- 申請號碼
- 2019439
- 國家/地區
- 荷蘭
欲了解更多信息，請點擊 這裡
